ProMIS Neurosciences

ProMIS Neurosciences

ProMIS Neurosciences

We are a development stage biotech company harnessing the power of precision medicine to conquer Alzheimer’s disease and ALS.
Type
B2b
Raised
$722.5k
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$262,500
Grant - 2017
Canadian Institutes of Health Research
$460,000
Venture capital (Series UNDISCLOSED) - 2016
Team Size
1–10
Employees
Location
Headquarters
the home of AI info

Stock under Close Observation: ProMIS Neurosciences (TSX:PMN)

the home of AI info

Hot Watch List: ProMIS Neurosciences (OTC:ARFXF)

the home of AI info

Stock Buzz: ProMIS Neurosciences (TSX:PMN)

the home of AI info

Stock Have a Latest Story: ProMIS Neurosciences (OTC:ARFXF)

the home of AI info

Stock under Close Observation: ProMIS Neurosciences (OTC:ARFXF)

the home of AI info

ProMIS Neurosciences Announces Fiscal Year 2019 Annual Results

the home of AI info

Why ProMIS Neurosciences, Inc.’s (TSE:PMN) CEO Pay Matters To You

the home of AI info

ProMIS Neurosciences Initiates Natural History Study of Blood-Based Biomarkers in Alzheimer’s …

the home of AI info

ProMIS Neurosciences Announces Gross Proceeds of $1257970 Related to the Exercise of …

the home of AI info

Can You Imagine How Chuffed ProMIS Neurosciences’s (TSE:PMN) Shareholders Feel About Its …

the home of AI info

ProMIS Neurosciences to Participate in Noble Capital Markets 16th Annual Investor Conference

the home of AI info

ProMIS Neurosciences to Participate in Noble Capital Markets 16th Annual Investor Conference

the home of AI info

ProMIS Neurosciences, Inc.

the home of AI info

ProMIS Neurosciences Inc.

the home of AI info

Is ProMIS Neurosciences, Inc. (TSE:PMN) Overpaying Its CEO?

the home of AI info

ProMIS Neurosciences to Participate in the BIO CEO & Investor Conference

the home of AI info

ProMIS Neurosciences Data for Alzheimer's Disease Program Targeting Tau Accepted for ...

the home of AI info

ProMIS Neurosciences Data for Alzheimer's Disease Program Targeting Tau Accepted for ...

the home of AI info

ProMIS Neurosciences Appoints Dr. José Luis Molinuevo to its Scientific Advisory Board

the home of AI info

ProMIS Neurosciences to present at Sachs 3rd Annual Neuroscience Innovation Forum